top of page

The Alzheimer's Drugs Showing Early Promise

Treatment for Alzheimer's disease, the devastating condition that affects more than 5 million Americans, has remained notoriously elusive for decades. Now, a small study released by drug company Eli Lilly offers at least a flicker of hope: It shows that the experimental drug donanemab may significantly slow patients’ cognitive decline.




Commentaires


Featured Posts
Recent Posts
Archive
Search By Tags
bottom of page